| Erik Swanson, MD | |
|
1849 Savage Rd, Charleston, SC 29407-4726 | |
| (843) 766-7103 | |
| Not Available |
| Full Name | Erik Swanson |
|---|---|
| Gender | Male |
| Speciality | Otolaryngology |
| Experience | 18 Years |
| Location | 1849 Savage Rd, Charleston, South Carolina |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1114074937 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207Y00000X | Otolaryngology | MMD.33912 (South Carolina) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Trident Medical Center | Charleston, SC | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Charleston Ent Associates, Llc | 4082662234 | 64 |
News Archive
The ATS congratulates the FDA on its important, but belated action, to remove flavored e-cigarette products from the U.S. market. Since e-cigarette products first emerged in the U.S., the American Thoracic Society has consistently called on FDA to aggressively regulate e-cigarettes and has repeatedly urged the FDA to ban flavored e-cigarettes from the U.S. market.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
UC Irvine researchers have found that a protein best known for building connections between nerve cells and muscle also plays a role in controlling brain cell activity.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
› Verified 8 days ago
| Entity Name | Charleston Ent Associates, Llc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1588607303 PECOS PAC ID: 4082662234 Enrollment ID: O20050105000267 |
News Archive
The ATS congratulates the FDA on its important, but belated action, to remove flavored e-cigarette products from the U.S. market. Since e-cigarette products first emerged in the U.S., the American Thoracic Society has consistently called on FDA to aggressively regulate e-cigarettes and has repeatedly urged the FDA to ban flavored e-cigarettes from the U.S. market.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
UC Irvine researchers have found that a protein best known for building connections between nerve cells and muscle also plays a role in controlling brain cell activity.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
› Verified 8 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Erik Swanson, MD 1849 Savage Rd, Charleston, SC 29407-4726 Ph: (843) 766-7103 | Erik Swanson, MD 1849 Savage Rd, Charleston, SC 29407-4726 Ph: (843) 766-7103 |
News Archive
The ATS congratulates the FDA on its important, but belated action, to remove flavored e-cigarette products from the U.S. market. Since e-cigarette products first emerged in the U.S., the American Thoracic Society has consistently called on FDA to aggressively regulate e-cigarettes and has repeatedly urged the FDA to ban flavored e-cigarettes from the U.S. market.
Anadys Pharmaceuticals, Inc. announced today that it has entered into definitive agreements with certain institutional investors to raise approximately $12.5 million in gross proceeds in a "registered direct" offering through the sale of a total of 5,813,954 shares of its common stock at an offering price of $2.15 per share. Anadys estimates that net proceeds from the offering will be approximately $11.3 million, after deducting placement agents' fees and estimated offering expenses.
UC Irvine researchers have found that a protein best known for building connections between nerve cells and muscle also plays a role in controlling brain cell activity.
Collegium Pharmaceutical, Inc., a specialty pharmaceutical company, today announced that it has received Notice of Allowance from the U.S. Patent and Trademark Office for its patent application "Abuse-Deterrent Drug Formulations", US Patent Application Number 11/149,867. The Notice of Allowance is the USPTO's official communication that the Company's application has successfully completed examination and that a patent will be issued.
Today, Seattle Children's and Puget Sound Blood Center opened a new blood laboratory to serve Children's patients exclusively. Located within Seattle Children's main campus and staffed by Puget Sound Blood Center employees 24 hours every day of the year, the facility will bring the lab closer to the patient.
› Verified 8 days ago
Jenna Hanner Barengo, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 169 Ashley Ave Rm 202, Charleston, SC 29425 Phone: 740-525-0170 | |
Ronald James Mcvicar, DO Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1849 Savage Rd, Charleston, SC 29407 Phone: 843-766-7103 Fax: 843-576-2692 | |
Nicole Kloosterman, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 135 Rutledge Ave # Msc550, Charleston, SC 29425 Phone: 843-792-8299 | |
Dr. Mark Drury Ghegan, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 1849 Savage Rd, Charleston, SC 29407 Phone: 843-766-7103 Fax: 843-763-3834 | |
Anthony Ghanem, MD Otolaryngology Medicare: Medicare Enrolled Practice Location: 135 Rutledge Ave Ste 1130, Charleston, SC 29425 Phone: 843-876-0791 Fax: 843-792-0546 | |
Dr. David Watson Rodwell Iii, M.D. Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 67 Broad St, Suite 200, Charleston, SC 29401 Phone: 843-628-1415 | |
Ted Meyer, MD Otolaryngology Medicare: Accepting Medicare Assignments Practice Location: 171 Ashley Ave, Charleston, SC 29425 Phone: 843-792-1414 |